Abstract
In recent years, Deep Brain Stimulation (DBS) treatments have attracted great interest in the medical community, not only for their effectiveness, but also for their expanded, potential future applications. With these great hopes come various accompanying ethical challenges. DBS is a psychosurgical invasive intervention commonly used to treat various symptoms of neurodegenerative diseases. For instance, the most common application of DBS treatments has targeted Parkinson’s symptoms such as tremor, rigidity, stiffness, slowed movement, or even walking problems. The technique consists of implanting a battery-operated neuromedical device which delivers an electrical stimulation to a specific area of the patient’s brain. However, due to its invasive nature, in order to qualify for DBS treatment, patients must be in an advanced phases of a neurodegenerative disease and have demonstrated resistance to pharmacological treatment. However, in the future, developments in medical nanotechnologies hold the potential to render the DBS procedure less invasive, thereby expanding the safety and range of applications for these technologies.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
